ZAGREB, Oct 3 (Hina) - A company of Croatia's pharmaceutical company Pliva in the United States, Sidmak, purchased last year, has launched a new innovative generic brand on the US market, namely, a bronchospasmolitic with improved
therapeutic characteristics, Pliva reported on Thursday.
ZAGREB, Oct 3 (Hina) - A company of Croatia's pharmaceutical
company Pliva in the United States, Sidmak, purchased last year,
has launched a new innovative generic brand on the US market,
namely, a bronchospasmolitic with improved therapeutic
characteristics, Pliva reported on Thursday. #L#
According to information by the International Medical Statistics
for 2001, the sale of equivalents to this drug on the American
market amounted to 56.8 million dollars.
(hina) lml sb